Ann: Research Coverage on CHP - Independent Investment Research, page-14

So the report values CHP as at 4/5/17 at .027c per share on current revenue performance.

Now i'm thinking we may see more than one Medical Cannibas deal finalised in coming weeks.

"CIL is currently in advanced stage negotiations with a number of substantial high quality medicinal cannabis investment opportunities"

Leads me to believe they are negotiating more than one deal there......

Share price will be a lot higher than .027c if they negotiate several high quality Medical Cannibas deals in North America. The market is massive there. Expected to reach $20 Billion by 2021. 1% of that market is $200 million. That 50 times current company revenue. Imagine a share price 50 times higher in a few years from now....

Not long now